J&J Medical Connect
  • Home/
  • Products/
  • TECVAYLI®/
  • Current page
TECVAYLI®

(teclistamab-cqyv)

+ Save link

TECVAYLI® (teclistamab-cqyv)

  • icon-pdfFull Prescribing Information including BOXED WARNING (English)
  • icon-pdfFull Prescribing Information including BOXED WARNING (Spanish)
  • icon-pdfMedication Guide (English)
  • icon-pdfMedication Guide (Spanish)
  • Risk Evaluation and Mitigation Strategy (REMS)


Pivotal clinical trial publications

MajesTEC-1 (MMY1001)

  • Moreau P,  Garfall AL,  van de Donk NWCJ, et al. Teclistamab in relapsed or refractory multiple myeloma. N Engl J Med. 2022;387(6):495-505.
  • Usmani SZ,  Garfall AL,  van de Donk N, et al. Teclistamab,  a B-cell maturation antigen x CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study. Lancet. 2021;398(10301):665-674.
  • Report an adverse eventchevronright
  • Report a product quality complaintchevronright

Contact J&J Medical Connect for your medical inquiries

  • Chat live
  • SearchMedical information
  • Connect with my MSL
  • Call me now
  • Email
  • Call 1-800-526-7736
  • Live video
Loading Common Footer...
Loading Common Footer...
J&J Medical Connect

Connect with us

Connect with us

    Connect with my medical science liaison

    Connect with my medical science liaison

    Chat live

    Chat live

    Available Monday - Friday 9AM - 4:30PM ET

    Call me now

    Call me now

    Available Monday - Friday 9AM - 7:30PM ET

    Email your inquiry

    Email your inquiry

    Call 1-800-526-7736

    Call 1-800-526-7736

    Available Monday - Friday 9AM - 8PM ET

    Live video

    Live video

    Available Monday - Friday 9AM - 4:30PM ET

Endchat
Chat live

Live video

Waiting for agent...

A Medical Information Specialist will assist you shortly. When your Specialist has joined, a button to join the video call will appear here.

Ready to join

Click or tap the button below to join the video call with your Medical Information Specialist:

Join now

Would you like to clear and leave your conversation? Message history will be lost.